Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Viatris Stock News

VTRSNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

Q1 2025 Earnings in 13 days from now on Thu May 8th, before the market open

Viatris (VTRS) Forecast

News

Earnings Viatris (VTRS) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Latest Viatris Stock News | NASDAQ:VTRS | Benzinga

Get the latest news on Viatris stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Viatris performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, April 21, 2025

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
Avi Kapoor - 4 days ago
Viatris Has Filed Applications To The Ministr...
Benzinga Newsdesk - 4 days ago

Monday, April 07, 2025

Viatris Agrees To $335 Million Opioid Settlement Framework
Vandana Singh - Apr 7, 2025, 11:54AM
Viatris shares are trading lower after the co...
Benzinga Newsdesk - Apr 7, 2025, 9:47AM
Viatris Reached A Nationwide Settlement Frame...
Benzinga Newsdesk - Apr 7, 2025, 7:02AM

Friday, April 04, 2025

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 4% Dividend Yields
Avi Kapoor - Apr 4, 2025, 8:50AM

Friday, March 07, 2025

Jefferies Maintains Buy on Viatris, Lowers Pr...
Benzinga Newsdesk - Mar 7, 2025, 12:17PM

Wednesday, March 05, 2025

Forecasting The Future: 4 Analyst Projections For Viatris
Benzinga Insights - Mar 5, 2025, 1:01PM
Piper Sandler Reiterates Neutral on Viatris, ...
Benzinga Newsdesk - Mar 5, 2025, 10:53AM

Sunday, March 02, 2025

Tesla, Palantir And MicroStrategy Are Among Top 12 Large-Cap Losers Last Week (Feb 24-Feb 28): Are The Others In Your Portfolio?
Lekha Gupta - Mar 2, 2025, 9:30AM

Friday, February 28, 2025

Barclays Maintains Underweight on Viatris, Lo...
Benzinga Newsdesk - Feb 28, 2025, 5:56PM
B of A Securities Maintains Underperform on V...
Benzinga Newsdesk - Feb 28, 2025, 7:46AM
Reported Earlier, Nxera Pharma Assigns Ceneri...
Benzinga Newsdesk - Feb 28, 2025, 2:24AM

Thursday, February 27, 2025

Viatris Stock Tumbles On Q4 Earnings Miss, FDA Warning Clouds 2025 Outlook
Vandana Singh - Feb 27, 2025, 1:59PM
Viatris shares are trading lower after the co...
Benzinga Newsdesk - Feb 27, 2025, 7:06AM
Viatris shares are trading lower after the co...
Benzinga Newsdesk - Feb 27, 2025, 6:55AM
Viatris FY2025 Outlook: Adj EPS $2.12-$2.26 v...
Benzinga Newsdesk - Feb 27, 2025, 6:54AM
Viatris Q4 2024 Adj EPS $0.54 Misses $0.57 Es...
Benzinga Newsdesk - Feb 27, 2025, 6:53AM
Earnings Scheduled For February 27, 2025
Benzinga Insights - Feb 27, 2025, 3:32AM

Tuesday, January 14, 2025

Viatris Exec Says Co Is Uniquely Positioned T...
Benzinga Newsdesk - Jan 14, 2025, 11:48AM

Monday, January 06, 2025

CVS Health's Aetna Files Lawsuit Against Drugmakers For Alleged Inflated Generic Drug Prices
Vandana Singh - Jan 6, 2025, 10:40AM

Monday, December 23, 2024

Viatris Issues Statement Regarding Receipt Of...
Benzinga Newsdesk - Dec 23, 2024, 8:26AM

Sunday, December 22, 2024

Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Vandana Singh - Dec 22, 2024, 2:51PM

Wednesday, December 18, 2024

Viatris Announces Publication Of Phase 2b CAR...
Benzinga Newsdesk - Dec 18, 2024, 7:03AM

Friday, December 06, 2024

Piper Sandler Reiterates Neutral on Viatris, ...
Benzinga Newsdesk - Dec 6, 2024, 9:20AM

Thursday, November 07, 2024

Wall Street Hits Record Highs After Powell's Speech, Lifts Magnificent 7 Stocks To $17 Trillion In Historic Trading
Piero Cingari - Nov 7, 2024, 4:51PM
Generic Drugmaker Viatris Beats Expectations In Q3, CEO Praises $2 Billion Debt Paydown
Vandana Singh - Nov 7, 2024, 12:39PM
Viatris shares are trading higher after the c...
Benzinga Newsdesk - Nov 7, 2024, 10:47AM
Viatris Lowers FY24 Adj EPS Guidance from $2....
Benzinga Newsdesk - Nov 7, 2024, 7:15AM
Viatris Q3 2024 Adj. EPS $0.75 Beats $0.68 Es...
Benzinga Newsdesk - Nov 7, 2024, 7:12AM

Saturday, November 02, 2024

These 10 Stocks Were S&P 500's Worst Performers In Biden's First Year: Could Trend Continue If Harris Wins 2024 Election?
Chris Katje - Nov 2, 2024, 8:58AM

Friday, November 01, 2024

FDA Panel Rejects Lexicon's Zynquista For Type 1 Diabetes
Vandana Singh - Nov 1, 2024, 9:05AM

Wednesday, October 16, 2024

Lexicon Announces Exclusive Licensing Agreeme...
Benzinga Newsdesk - Oct 16, 2024, 4:36PM

Wednesday, October 09, 2024

Viatris Announced Topline Results From Its Ph...
Benzinga Newsdesk - Oct 9, 2024, 7:04AM

Monday, October 07, 2024

Novo Nordisk Settles US Patent Dispute With V...
Benzinga Newsdesk - Oct 7, 2024, 2:36PM

Monday, September 30, 2024

Viatris Launches Viagra ODF in Canada, A New ...
Benzinga Newsdesk - Sep 30, 2024, 7:00AM

Tuesday, September 24, 2024

Why Is Regeneron Pharmaceuticals Stock Trading Lower On Tuesday?
Vandana Singh - Sep 24, 2024, 2:21PM

Friday, September 20, 2024

EXCLUSIVE: Options Expert Warns Of 'Terrible Week' After Friday's Triple Witching
Piero Cingari - Sep 20, 2024, 10:51AM

Wednesday, September 18, 2024

Viatris Announces Pricing Terms Of $575M Maxi...
Benzinga Newsdesk - Sep 18, 2024, 11:31AM

Tuesday, September 10, 2024

Viatris Announces The Pricing Terms Of Cash T...
Benzinga Newsdesk - Sep 10, 2024, 11:44AM

Friday, September 06, 2024

JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability
Vandana Singh - Sep 6, 2024, 1:46PM
Shortage Relief: More Takeda's Vyvanse For ADHD On the Way As US Ramps Up Production
Vandana Singh - Sep 6, 2024, 9:46AM

Friday, August 23, 2024

Viatris Says Late-breaking Oral Presentation ...
Benzinga Newsdesk - Aug 23, 2024, 7:00AM

Thursday, August 15, 2024

10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights - Aug 15, 2024, 1:35PM

Thursday, August 08, 2024

US Drugmaker Viatris Q2 Earnings Edge Out Analysts Expectation On Strong Demand For Branded And Generic Drugs
Vandana Singh - Aug 8, 2024, 1:54PM
Viatris shares are trading higher after the c...
Benzinga Newsdesk - Aug 8, 2024, 8:21AM
Viatris Expects 2024 Adjusted EPS Of $2.58-$2...
Benzinga Newsdesk - Aug 8, 2024, 7:13AM
Viatris Expects 2024 Sales Of $14.6B-$15.1B V...
Benzinga Newsdesk - Aug 8, 2024, 7:12AM
Viatris Q2 2024 Adj. EPS $0.69 Beats $0.68 Es...
Benzinga Newsdesk - Aug 8, 2024, 7:01AM

Tuesday, August 06, 2024

Theravance Q2 Loss Wider Than Expected, Revenues Rise Y/Y
Zacks - Aug 6, 2024, 3:50PM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved